OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages. - Wikidata - wikimedia - TriplyDB

OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages.

OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages.

http://www.wikidata.org/entity/Q40262380

about

Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect Oxidized Low-Density Lipoprotein Immune Complex Priming of the Nlrp3 Inflammasome Involves TLR and FcγR Cooperation and Is Dependent on CARD9 Heat shock protein 70B' (HSP70B') expression and release in response to human oxidized low density lipoprotein immune complexes in macrophages Clinical significance of the humoral immune response to modified LDL.Differential trafficking of oxidized LDL and oxidized LDL immune complexes in macrophages: impact on oxidative stress.Oxidized LDL: diversity, patterns of recognition, and pathophysiology.Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.Response to comment on Lopes-Virella et al. Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects. Diabetes care 2013;36:2317-2323.LDL-containing immune complexes in the DCCT/EDIC cohort: associations with lipoprotein subclasses.Inflammation in the pathogenesis of microvascular complications in diabetes.An immunohistochemical analysis to validate the rationale behind the enhanced immunogenicity of D-ribosylated low density lipo-protein.Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes.Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes.The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE(-/-) mice Oxidized LDL immune complexes stimulate collagen IV production in mesangial cells via Fc gamma receptors I and III.Longitudinal Association Between Endothelial Dysfunction, Inflammation, and Clotting Biomarkers With Subclinical Atherosclerosis in Type 1 Diabetes: An Evaluation of the DCCT/EDIC Cohort High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes.Immune complexes isolated from patients with pulmonary tuberculosis modulate the activation and function of normal granulocytes Highly specific inhibition of C1q globular-head binding to human IgG: a novel approach to control and regulate the classical complement pathway using an engineered single chain antibody variable fragment.Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy.Atherogenesis and the humoral immune response to modified lipoproteins Association of serum levels of lipid and its novel constituents with the different stages of esophageal carcinoma.Elevated Levels of Plasma IgA Autoantibodies against Oxidized LDL Found in Proliferative Diabetic Retinopathy but Not in Nonproliferative Retinopathy Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes.The role of immune complexes in atherogenesis.Auto-antibodies as emergent prognostic markers and possible mediators of ischemic cardiovascular diseases.Inflammation in diabetic nephropathy.Effect of diet-derived advanced glycation end products on inflammation.Differential regulation of acid sphingomyelinase in macrophages stimulated with oxidized low-density lipoprotein (LDL) and oxidized LDL immune complexes: role in phagocytosis and cytokine release.The Pathogenic Role of the Adaptive Immune Response to Modified LDL in Diabetes.Oxidized LDL immune complexes and oxidized LDL differentially affect the expression of genes involved with inflammation and survival in human U937 monocytic cells.Plasma IgA antibody levels to malondialdehyde acetaldehyde-adducts are associated with inflammatory mediators, obesity and type 2 diabetes.Oxidative Stress in the Local and Systemic Events of Apical Periodontitis.Immunoassay of modified forms of human low density lipoprotein in isolated circulating immune complexes.B cells in type 1 diabetes mellitus and diabetic kidney disease.Detection of Circulating Auto-Antibodies Against Ribosylated-LDL in Diabetes Patients.

P2860

Q28553042-4F762B53-A18D-49E3-9E05-EFAC0E1612B7 Q30274903-97B997A4-5AD2-4203-81D9-A857D0C99A7B Q30494525-EC0C21D7-0102-42FB-BF25-7229D20C1B82 Q33598770-7F15C470-6693-4596-8393-5E708366E486 Q33686991-82910D34-B860-4ADE-BD63-EF6F360EC93B Q33879138-0C0E3F3C-AA8C-40D2-9E24-20E772F2F4DC Q34072528-C8BECE40-560A-487C-8249-FB282FB7A90A Q34278935-22CAA0D4-9158-43A6-B6B5-9B66DEDB42CD Q34300099-8314BEC3-450D-4E91-BB13-3AF26135A726 Q34319638-BBD477B8-D7DB-4A38-A744-7498709F7BD9 Q34506699-397EA16F-4C69-48FD-99EB-3F070FA28D1B Q34527165-8DB670B8-568A-4732-A0A8-4B346F6C6428 Q34542912-4878ED82-8F5E-4427-B3ED-40076D934C46 Q34557344-2EFE8D2D-7E0E-43BA-AB5B-EA297B4389F5 Q34656412-9C0E33C3-5233-47E4-AD63-6E86B8D79AA9 Q34988136-5B8BB913-0E9A-4A2D-9EE0-DA9DCF73E16E Q35769521-D69A8EC0-331A-4E9E-BEB8-A99AF04DB718 Q35976427-4BB9C56F-AB10-496E-800B-3292BB07C168 Q36505215-0D413842-09D6-4E2E-A955-99C34918C55D Q36669875-F15F0F5B-BFBD-4F05-9996-32373F0D4805 Q37012519-3388238D-CFAB-45B5-AE98-8040AD4AE60F Q37021490-826AC747-F7CD-4243-BAC8-F8C84C711506 Q37417665-E93B0D81-6664-407D-977F-BB13E7FE2FDA Q37549608-313D96F0-00DA-497B-8FE8-3DECA5FC88C8 Q37584378-86FF56A0-E0DB-4CF2-80E9-80AD8254E574 Q37731718-3B29FB3C-93FC-4A30-B036-B547C29E6854 Q37824302-148BF9BC-9B91-4203-AD4B-A7AC0F99F4A2 Q38042593-0983186C-A9AC-47A0-A3E1-208396BD4BB8 Q38588208-4A43CEFE-198E-4AA6-968D-B96775D3ABED Q39413836-59457C2D-20C1-4C4E-A17D-3A9AC3B52CE2 Q42201820-142DBA13-BB75-4DC4-AA4D-E26F22CF075F Q43193872-DBB0EB02-8EE6-497B-A83C-67882310F78C Q43523503-570BFB8A-BB82-4D98-9C44-547BC26826DA Q45978766-1414CDBB-471E-40AE-AB56-B9095EA65E08 Q46380048-7BAFF796-B002-4B4B-B2A4-5F5C5C0B4604 Q50077505-DA5038F3-6778-49D0-A9C2-278D9CC45068 Q51550442-04D1E72D-7CD8-4191-A532-6A5BD31FD739

P2860

OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages.

http://www.wikidata.org/entity/Q40262380

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

OxLDL immune complexes activat ...... 6 cells and human macrophages.

@en

type

label

OxLDL immune complexes activat ...... 6 cells and human macrophages.

@en

prefLabel

OxLDL immune complexes activat ...... 6 cells and human macrophages.

@en

P1433

Q40262380-1C341533-AF87-4AA0-9BA8-869CB63916E8

P1476

Q40262380-3998AB4B-9816-4B69-9C3B-4E7E55321C69

P2093

Q40262380-163887B1-1836-47EF-BCC7-2723A1F8FD41

Q40262380-65649F54-5ABC-4FB2-BF0D-AA2FB5989B78

Q40262380-89AC07F9-7C91-4898-8D77-4279FEE47CCC

Q40262380-AF3FDB86-5D72-45B3-9BDB-A0E8BF8A1C32

Q40262380-DEC8457D-2861-4C33-8510-3C0839868DF7

P2860

Q40262380-0047D758-BFE4-4325-A9D9-308E3695005A

Q40262380-0E25E60C-7F21-40DA-933D-9D22BBE563ED

Q40262380-10E2CADE-E78A-4506-959A-956A32C27A76

Q40262380-1EF8B9F4-49BB-4778-B3FC-F820A209EEA4

Q40262380-2BBABCC8-4954-4801-8010-07CDBB164996

Q40262380-2C81E318-AE8D-4277-AE26-226E84BBADB2

Q40262380-2E890CA0-973D-4F28-8A18-FE94C0B09381

Q40262380-4A8F86BF-8B51-4B1E-B293-F3F0F2FC0823

Q40262380-4FE6E11A-DDB7-45F5-9735-016183A7E3D5

Q40262380-5C423038-5F65-48F2-96D3-A282D26B7AED

P304

Q40262380-9E47AC6F-FB9F-44A6-89AF-7854D8060DA8

P31

Q40262380-57668227-A7A1-48FB-9AF8-5221F890E673

P356

Q40262380-1585998C-C3EE-4EC1-94BA-75147BCFD977

P433

Q40262380-E418587C-5E8C-497D-9831-916EB36D684E

P478

Q40262380-CB9EFE34-FEA5-4F0A-A85A-10730A65FF3B

P577

Q40262380-82DBA18D-E74A-4D03-94D7-9EB03110053C

P698

Q40262380-DA6B93B8-A29D-41BB-B962-7A01C2830563

P356

JLR.M600064-JLR200

P1433

Journal of Lipid Research

P1476

OxLDL immune complexes activat ...... 6 cells and human macrophages.

@en

P2093

Antonio F Saad

http://www.w3.org/2001/XMLSchema#string

Charlyne Chassereau

http://www.w3.org/2001/XMLSchema#string

Gabriel Virella

http://www.w3.org/2001/XMLSchema#string

Maria F Lopes-Virella

http://www.w3.org/2001/XMLSchema#string

Robert J Boackle

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man

Inflammation in atherosclerosis

Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo.

Inflammation and immune response in atherosclerosis.

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis

Autoimmunity, oxidized LDL and cardiovascular disease.

The role of immune and inflammatory processes in the development of macrovascular disease in diabetes.

Role of complement activation in atherosclerosis.

The role of complement activation in atherosclerosis.

The role of natural antibodies in atherogenesis.

P304

1975-1983

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1194/JLR.M600064-JLR200

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16804192

http://www.w3.org/2001/XMLSchema#string